The very favorable metastatic renal cell carcinoma (mRCC) risk group: Data from the International Metastatic RCC Database Consortium (IMDC).

Andrew Schmidt,Wanling Xie,Chun Loo Gan,Connor Wells,Shaan Dudani,Frede Donskov,Camillo Porta,Cristina Suárez,Bernadett Szabados,Lori Wood,José Manuel Ruiz-Morales,Ben Tran,Georg A. Bjarnason,Takeshi Yuasa,Benoit Beuselinck,Aaron R. Hansen,Neeraj Agarwal,Ziad Bakouny,Daniel Yick Chin Heng,Toni K. Choueiri

The very favorable metastatic renal cell carcinoma (mRCC) risk group: Data from the International Metastatic RCC Database Consortium (IMDC).

2021

339Background: The IMDC criteria have been used as a prognostic tool for patients with mRCC receiving single agent VEGF-targeted drugs, and more recently combination immuno-oncology (IO) +/- VEGF-t...

Keywords:

Oncology
Renal cell carcinoma
risk groups
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations